• WCG Introduces Velos eResearch eXpress™

    Aug 27, 2019, 08:18 AM by Michael Croft
    PRINCETON, NJ - Aug 27, 2019 - The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division introduces Velos eResearch eXpress™, an out-of-the-box, cloud-based solution that enables clinical research sites to centralize and manage their research activities on a single, automated technology platform
    Full story

  • Microway Provides Vyasa Analytics With NVIDIA DGX-1, NumberSmasher GPU Server

    Aug 26, 2019, 15:15 PM by Michael Croft

    Bio-IT World Brief | Microway announced it has provided an NVIDIA DGX-1 supercomputer and Microway NumberSmasher Tesla GPU Server to Vyasa Analytics.

    Full story

  • Researchers Beginning To Use CRISPR In Studies

    Aug 26, 2019, 15:05 PM by Michael Croft

    Bio-IT World | After years of discussion, patent lawsuits, and hype, the gene-editing tool know as CRISPR is finally making its way into clinical trials.

    Full story

  • The Next Trick For CRISPR Is Gene-Editing Pain Away

    Aug 23, 2019, 09:35 AM by Michael Croft

    MIT Technology Review | A family of street performers could walk on coals. Scientists have paired the discovery with the gene-editing tool CRISPR, in what they say is a step toward a gene therapy that could block severe pain caused by diabetes, cancer, or car accidents without the addictive effects of opioids.

    Full story

  • Microway Provides Vyasa Analytics NVIDIA® DGX-1™ and NumberSmasher® GPU Server

    Aug 21, 2019, 12:22 PM by Michael Croft
    PLYMOUTH, MA - Aug 21, 2019 - Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC applications, announces it has provided an NVIDIA® DGX-1™ supercomputer and Microway NumberSmasher® Tesla® GPU Server to deep-learning leader Vyasa Analytics
    Full story

  • Color Receives Genetic Counseling Grant for All of Us

    Aug 21, 2019, 11:20 AM by Michael Croft
    Bio-IT World  | The All of Us research program has awarded $4.6 million in initial funding to Color, a health technology company in Burlingame, California, to establish the program’s nationwide genetic counseling resource. Through this funding, Color’s network of genetic counselors will help participants understand what the genomic testing results mean for their health and their families.
    Full story

  • Signant Health Appoints Todd Everhart as Clinical Vice President to Accelerate Intelligent eCOA and Predictive Data Analytics in Medical Clinical Research

    Aug 20, 2019, 10:27 AM by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Aug 20, 2019 - Signant Health, formerly CRF Health and Bracket, has appointed Anthony Todd Everhart, MD, FACP to the Signant Health Science and Medicine Team as Clinical Vice President, Internal Medicine, reporting to the Chief Medical Officer, Dr
    Full story

  • Creative Diagnostics Introduces New Lyophilized Exosomes for Research

    Aug 20, 2019, 04:18 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Aug 20, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announces that it has developed lyophilized exosomes for global researchers, which are isolated from different biological sources including human biofluids of certified healthy donors (plasma, serum, urine, saliva) and different cell culture supernatant
    Full story

  • Knopp Biosciences Announces Start of Phase 2 Clinical Trial Evaluating Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma

    Aug 19, 2019, 14:56 PM by Michael Croft
    PITTSBURGH, PA - Aug 19, 2019 - Knopp Biosciences LLC today announced the start of Phase 2 dose-ranging clinical trial in moderate-to-severe eosinophilic asthma
    Full story

  • Strata Oncology Announces Partnerships with Five Additional Health Systems

    Aug 17, 2019, 14:08 PM by Michael Croft
    BELFORD, NJ, US - Aug 16, 2019 - ANN ARBOR, Mich. -- Strata Oncology, a precision oncology company enabling molecular indications for cancer therapeutics, today announced Baptist Health (KY), Lehigh Valley Health Network (PA), Marshfield Clinic (WI), MultiCare Health System (WA), and Prisma Health (SC) have joined the Strata Precision Oncology Network™ (the "Network")
    Full story

  • U.K. Firm Creates Operating System To Handle Massive Genomic Patient Data Sets

    Aug 16, 2019, 17:38 PM by Michael Croft
    Forbes | We're making work digital on every desktop, we're empowering digital sensors in the Internet of Things (IoT) on every street corner, we're building smart digital AI-powered IT systems with machine learning and decision-making abilities to automate our lives… and we're digitizing ourselves as well.
    Full story

  • Creative Enzymes Has Upgraded Four Enzymes Services for Bio-researchers

    Aug 16, 2019, 04:47 AM by Michael Croft
    NEW YORK, NY - Aug 16, 2019 - As an excellent supplier and manufacturer, Creative Enzymes recently has upgraded four enzymes related services, such as enzyme expression and purification, and enzyme engineering services for researchers working in the life science field
    Full story

  • 20% Enrollment For All of Us Program, Challenges Remain

    Aug 15, 2019, 12:55 PM by Michael Croft
    Bio-IT World | The All of Us research program announced updates today in a special report published in the New England Journal of Medicine. As of July 2019, the All of Us program has enrolled more than 175,000 core participants (those who contributed personal information, biospecimens, and physical measurements and who agreed to share EHR data) and more than 230,000 total participants; an additional 40,000 participants have registered on the website, the authors report. “More than 80% of these participants are from groups that have been historically underrepresented in biomedical research,” the authors observe.
    Full story

  • New BioIVT Research Examines Potential Link Between HIV Integrase Inhibitor Drugs and Neural Tube Defects During Pregnancy

    Aug 15, 2019, 08:28 AM by Michael Croft
    WESTBURY, NY - Aug 15, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that researchers in its Transporter Sciences Group have co-authored a peer-reviewed DMD paper, which investigates the inhibitory effects of a class of HIV drugs known as integrase inhibitors on folate transporter pathways
    Full story

  • Size really does matter when purchasing equipment for laboratories

    Aug 14, 2019, 12:15 PM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Aug 14, 2019 - Laboratories are nearly always short of space which means bulky or very heavy equipment can’t be accommodated or has to be housed away from the laboratory
    Full story

  • Tackling the Affinity Gap at Amgen

    Aug 14, 2019, 11:55 AM by Michael Croft
    Bio-IT World At Amgen, Agnieszka Kielczewska had a problem. The AMGN12 antibody, derived from an in vivo immunization of the XenoMouse, demonstrated single digit pM affinity to the human orthologue of the target protein, but a 200-fold weaker binding to the monkey orthologue. In order to conduct toxicology studies in non-human primate species, Amgen needed that affinity difference to be closer to 10-fold.
    Full story

  • Creative Biolabs Has Updated Its Product Type for Therapeutic Antibodies

    Aug 14, 2019, 02:45 AM by Michael Croft
    SHIRLEY, NY - Aug 13, 2019 - August 13, 2019, as a leading supplier and manufacturer in antibody field, Creative Biolabs recently has updated its new product types for therapeutic antibody, which has at least three types of mechanisms
    Full story

  • Nvidia just made it easier to build smarter chatbots and slicker fake news

    Aug 13, 2019, 10:42 AM by Michael Croft
    MIT Technology Review | Chipmaker Nvidia is betting that AI's language skills will advance rapidly-it's releasing a powerful tool for putting together chatty programs.
    Full story

  • Biobanking Is Changing The World

    Aug 13, 2019, 10:29 AM by Michael Croft
    Forbes | With the evolution of biobanks rapidly enabling the creation of massive collections of biological material and associated information, how are these collected terabytes of data transforming nations?
    Full story

  • AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio

    Aug 13, 2019, 05:01 AM by Michael Croft
    RESEARCH TRIANGLE PARK, NC - Aug 13, 2019 - AskBio, the world’s foremost clinical stage and gene therapy platform company, has acquired Synpromics, the leader in gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables more precise cell targeting and gene expression
    Full story